Owlet Announces FDA Clearance of Dream Sock

Shop FDA-Cleared Dream Sock

The first and only non-prescription baby monitor with FDA-cleared Live Health Readings and Health Notifications for healthy babies between 1 to 18 months. Available to current and new Dream Sock users, starting at the end of 2023.

A new Dream Sock® experience is coming soon


Live Health Readings

Experience the peace of mind that comes with 'Live Health Readings' prominently displayed on your home screen, providing immediate reassurance with clear status updates, ensuring caregivers are informed and confident about their baby's well-being at a glance.


Health Notifications

Health Notifications are designed based on preset, clinically validated levels and will notify for low pulse rate, high heart rate, low oxygen saturation levels – empowering parents with the crucial knowledge if their immediate assistance is needed and why.

What this means for every baby and every caregiver

  • This new clearance will allow Dream Sock users to track their infant’s Live Health Readings, including pulse rate and oxygen saturation level.
  • The clearance includes Owlet’s new Health Notifications, which will alert parents with lights and alarm sounds when their child’s health readings fall outside of preset ranges.
  • Achieving De Novo clearance, the first of its kind, means the Owlet Dream Sock was clinically and technically tested and proven to be as accurate as medical-grade baby monitoring technology.
  • Available for healthy infants 1-18 months, 6-30 lbs.
  • These new FDA-cleared features will begin rolling out to both existing and new Dream Sock users at the end of this year, in the U.S. only.


Sign Up for Updates

Indications for Use statement:

The Dream Sock analyzes photoplethysmography data to identify instances when the infant’s pulse rate (PR) and/or oxygen saturation (SpO2) moves outside a preset range, and provides a notification to the caregiver, prompting them to assess the infant. The Dream Sock also displays the infant’s PR and SpO2 values to the caregiver and displays trends in these measured values, and their relationship to the preset ranges, over time. These PR and SpO2 notifications and displays on the Dream Sock are intended for use in infants who are 1 to 18 months of age and between 6 to 30 lbs.

The Dream Sock is intended for over-the-counter (OTC) use only in a home environment. It is not intended to provide notification for every episode of the unexpected occurrences of elevated or depressed PR or a low SpO2 level; rather, the Dream Sock is intended to provide a notification only when sufficient data are available for analysis. The notifications and associated data can be used to supplement the decision by caregivers to seek additional guidance for medical care of the infant.

The Dream Sock is not intended to replace traditional methods of monitoring, diagnosis or treatment.The Dream Sock is not intended for use with infants previously diagnosed with cardiovascular or respiratory disease or conditions.